Role of neutrophils in BCG immunotherapy for bladder cancer

This publication has 34 references indexed in Scilit:

• Identification of the Mycobacterial Subcomponents Involved in the Release of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand from Human Neutrophils
  Infection and Immunity, 2007
• Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators
  Journal of Leukocyte Biology, 2005
• IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
  Blood, 2004
• Neutrophil-Derived TNF-Related Apoptosis-Inducing Ligand (TRAIL)
  Cancer Research, 2004
• Regulation of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
  Immunology, 2004
• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Therapeutic potential of mycobacterial cell wall-DNA complexes
  Expert Opinion on Investigational Drugs, 2001
• Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin
  Cancer Immunology, Immunotherapy, 1991
• Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.
  Journal of Clinical Investigation, 1990
• Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.
  The Journal of cell biology, 1983